Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Ceftriaxone vs azithromycin Convalescent faecal carriage · children under 18 years of age with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Ceftriaxone vs azithromycin Serious adverse events · children under 18 years of age with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Ceftriaxone vs fluoroquinolones Serious adverse events · adults and children with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Cefixime vs fluoroquinolones Duration of hospital stay · adults and children with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Cefixime vs fluoroquinolones Convalescent faecal carriage · adults and children with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Cefixime vs fluoroquinolones Serious adverse events · adults and children with enteric fever Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins (2022) · Cochrane | no estimate extracted | NR | No studies |
Listening to music vs no treatment or treatment Adverse events · adults with insomnia Listening to music for insomnia in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Retrograde intramedullary nail (RIMN) vs locking plate Pain · adults with fractures of the distal femur Interventions for treating fractures of the distal femur in adults (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Back‐specific functional status · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs exercise Outcomesa · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Pain · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs exercise Depression · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Physical quality of life · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Mental quality of life · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Depression · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs sham yoga Adverse events · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Yoga vs non‐exercise Outcomesa · people with chronic non‐specific low back pain Yoga for chronic non‐specific low back pain (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs alginate gel Time‐to‐ulcer healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs alginate gel Health‐related quality of life · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs alginate gel Costs · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs manuka honey Change in ulcer size · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs manuka honey Time‐to‐ulcer healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs manuka honey Health‐related quality of life · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs manuka honey Costs · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressing vs hydrocolloid Complete ulcer healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs gauze and saline Incidence of wound infection · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressing vs hydrocolloid Incidence of wound infection · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressing vs hydrocolloid Time‐to‐ulcer healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressing vs hydrocolloid Health‐related quality of life · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressing vs hydrocolloid Costs · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs gauze and saline Time‐to‐ulcer healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs gauze and saline Health‐related quality of life · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs gauze and saline Costs · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs alginate gel Complete wound healing · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Hydrogel dressings vs alginate gel Incidence of wound infection · people with venous leg ulcers Hydrogel dressings for venous leg ulcers (2022) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings ‐ laser therapy vs no laser therapy Quality of life · children and adults with SCD and PSR Laser therapy for retinopathy in sickle cell disease (2022) · Cochrane | no estimate extracted | NR | No studies |
Physiotherapy vs minimal care Oerlemans 1999 Pain (VAS 0 to 100) · adults with CRPS I Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (2022) · Cochrane | no estimate extracted | NR | No studies |
Physiotherapy vs minimal care Incidence/nature of adverse effects · adults with CRPS I Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (2022) · Cochrane | no estimate extracted | NR | No studies |
Physiotherapy vs minimal care Pain (VAS 0 to 100) · adults with CRPS II Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (2022) · Cochrane | no estimate extracted | NR | No studies |
Physiotherapy vs minimal care Disability · adults with CRPS II Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (2022) · Cochrane | no estimate extracted | NR | No studies |
Physiotherapy vs minimal care Incidence/nature of adverse effects · adults with CRPS II Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II (2022) · Cochrane | no estimate extracted | NR | No studies |
Rilonacept vs placebo Prevention of AA amyloidosis · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
ImmunoGuard vs placebo Number of participants experiencing an attacka · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
ImmunoGuard vs placebo Duration of attacks · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
ImmunoGuard vs placebo Time between attacks · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
ImmunoGuard vs placebo Prevention of AA amyloidosis · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
Anakinra vs placebo Duration of attacks · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
Anakinra vs placebo Time between attacks · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
Anakinra vs placebo Prevention of AA amyloidosis · people with familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |
Canakinumab vs placebo Duration of attacks · people with colchicine‐resistant familial Mediterranean fever Interventions for reducing inflammation in familial Mediterranean fever (2022) · Cochrane | no estimate extracted | NR | No studies |